close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Yaqrit

News headline image
First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
From Yaqrit
Via GlobeNewswire
News headline image
First patient dosed in a proof-of-concept study of Yaqrit’s advanced microbiome therapeutic YAQ001 in patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit prepares phase 3 for ammonia scavenger in hepatic encephalopathy
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit appoints new CEO Troels Jordansen to implement late clinical development and commercial strategy
From Yaqrit
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.